Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Louis H Miller

Showing results (131-140 of 168) with videos related to

Pageof 17
Sort By:
Scientific Reports|July 18, 2020
Bliss' and Loewe's additive and synergistic effects in Plasmodium falciparum growth inhibition by AMA1-RON2L, RH5, RIPR and CyRPA antibody combinationsYvonne Azasi, Shannon K Gallagher, Ababacar Diouf, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2019
Transcriptome profiling of <i>Plasmodium vivax</i> in <i>Saimiri</i> monkeys identifies potential ligands for invasionKarthigayan Gunalan, Juliana M Sá, Roberto R Moraes Barros, et al.
Nature Communications|August 3, 2013
Disrupting malaria parasite AMA1-RON2 interaction with a small molecule prevents erythrocyte invasionPrakash Srinivasan, Adam Yasgar, Diane K Luci, et al.
Molecular and Biochemical Parasitology|December 17, 2008
Characterization of a protective Escherichia coli-expressed Plasmodium falciparum merozoite surface protein 3 indicates a non-linear, multi-domain structureChiawei W Tsai, Peter F Duggan, Albert J Jin, et al.
Trials|January 26, 2024
DON in pediatric cerebral malaria, a phase I/IIA dose-escalation safety study: study protocol for a clinical trialNginache Nampota-Nkomba, Osward M Nyirenda, Jane Mallewa, et al.
Microbes and Infection|January 17, 2009
Enhanced antibody responses to Plasmodium falciparum Pfs28 induced in mice by conjugation to ExoProtein A of Pseudomonas aeruginosa with an improved procedureFeng Qian, Joan A Aebig, Karine Reiter, et al.
Plos One|August 14, 2008
Phase 1 trial of AMA1-C1/Alhydrogel plus CPG 7909: an asexual blood-stage vaccine for Plasmodium falciparum malariaGregory E D Mullen, Ruth D Ellis, Kazutoyo Miura, et al.
The American Journal of Tropical Medicine and Hygiene|July 28, 2017
<i>Plasmodium vivax</i> Infections over 3 Years in Duffy Blood Group Negative Malians in Bandiagara, MaliAmadou Niangaly, Karthigayan Gunalan, Amed Ouattara, et al.
Vaccine|April 13, 2007
Conjugating recombinant proteins to Pseudomonas aeruginosa ExoProtein A: a strategy for enhancing immunogenicity of malaria vaccine candidatesFeng Qian, Yimin Wu, Olga Muratova, et al.
Vaccine|January 7, 2010
Phase 1 safety and immunogenicity trial of the Plasmodium falciparum blood-stage malaria vaccine AMA1-C1/ISA 720 in Australian adultsMark A Pierce, Ruth D Ellis, Laura B Martin, et al.
Pageof 17

Showing results (131-140 of 168) with videos related to

Sort By:
Pageof 17
Scientific Reports|July 18, 2020
Bliss' and Loewe's additive and synergistic effects in Plasmodium falciparum growth inhibition by AMA1-RON2L, RH5, RIPR and CyRPA antibody combinationsYvonne Azasi, Shannon K Gallagher, Ababacar Diouf, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2019
Transcriptome profiling of <i>Plasmodium vivax</i> in <i>Saimiri</i> monkeys identifies potential ligands for invasionKarthigayan Gunalan, Juliana M Sá, Roberto R Moraes Barros, et al.
Nature Communications|August 3, 2013
Disrupting malaria parasite AMA1-RON2 interaction with a small molecule prevents erythrocyte invasionPrakash Srinivasan, Adam Yasgar, Diane K Luci, et al.
Molecular and Biochemical Parasitology|December 17, 2008
Characterization of a protective Escherichia coli-expressed Plasmodium falciparum merozoite surface protein 3 indicates a non-linear, multi-domain structureChiawei W Tsai, Peter F Duggan, Albert J Jin, et al.
Trials|January 26, 2024
DON in pediatric cerebral malaria, a phase I/IIA dose-escalation safety study: study protocol for a clinical trialNginache Nampota-Nkomba, Osward M Nyirenda, Jane Mallewa, et al.
Microbes and Infection|January 17, 2009
Enhanced antibody responses to Plasmodium falciparum Pfs28 induced in mice by conjugation to ExoProtein A of Pseudomonas aeruginosa with an improved procedureFeng Qian, Joan A Aebig, Karine Reiter, et al.
Plos One|August 14, 2008
Phase 1 trial of AMA1-C1/Alhydrogel plus CPG 7909: an asexual blood-stage vaccine for Plasmodium falciparum malariaGregory E D Mullen, Ruth D Ellis, Kazutoyo Miura, et al.
The American Journal of Tropical Medicine and Hygiene|July 28, 2017
<i>Plasmodium vivax</i> Infections over 3 Years in Duffy Blood Group Negative Malians in Bandiagara, MaliAmadou Niangaly, Karthigayan Gunalan, Amed Ouattara, et al.
Vaccine|April 13, 2007
Conjugating recombinant proteins to Pseudomonas aeruginosa ExoProtein A: a strategy for enhancing immunogenicity of malaria vaccine candidatesFeng Qian, Yimin Wu, Olga Muratova, et al.
Vaccine|January 7, 2010
Phase 1 safety and immunogenicity trial of the Plasmodium falciparum blood-stage malaria vaccine AMA1-C1/ISA 720 in Australian adultsMark A Pierce, Ruth D Ellis, Laura B Martin, et al.
Pageof 17